NewReferencesToProblem: verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
 
(5 tussenliggende versies door dezelfde gebruiker niet weergegeven)
Regel 18: Regel 18:
|Current reference
|Current reference
|Replacement reference(s)
|Replacement reference(s)
|Old information model
|style="text-align:center;" |Current information model
|New information model
|style="text-align:center;" |New information model
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|width="20%" |[[Admission-v2.0(2024EN)| Admission]]
|width="20%" |[[Admission-v2.0(2024EN)| Admission]]
Regel 25: Regel 25:
|width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]]
|[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]]
Regel 31: Regel 32:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[Alert-v4.2(2024EN)| Alert]]
|[[Alert-v4.2(2024EN)| Alert]]
Regel 37: Regel 38:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]]
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]]
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]]
|
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[CareAgreement-v1.1(2024EN)| CareAgreement]]
|[[CareAgreement-v1.1(2024EN)| CareAgreement]]
Regel 43: Regel 44:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[CareTeam-v1.0.1(2024EN)| CareTeam]]
|[[CareTeam-v1.0.1(2024EN)| CareTeam]]
Regel 49: Regel 50:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[Encounter-v6.0(2024EN)| Encounter]]
|[[Encounter-v6.0(2024EN)| Encounter]]
Regel 55: Regel 56:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]]
|[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]]
Regel 61: Regel 62:
|[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]]
|[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]]
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[FamilyHistory-v4.0(2024EN)| FamilyHistory]]
|[[FamilyHistory-v4.0(2024EN)| FamilyHistory]]
Regel 67: Regel 68:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[MedicalDevice-v4.0(2024EN)| MedicalDevice]]
|[[MedicalDevice-v4.0(2024EN)| MedicalDevice]]
Regel 73: Regel 74:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]]
|[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]]
Regel 79: Regel 80:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]]
|[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]]
Regel 85: Regel 86:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[NursingIntervention-v4.1(2024EN)| NursingIntervention]]
|[[NursingIntervention-v4.1(2024EN)| NursingIntervention]]
Regel 91: Regel 92:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]]
|[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]]
Regel 97: Regel 98:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[Procedure-v5.4.1(2024EN)| Procedure]]
|[[Procedure-v5.4.1(2024EN)| Procedure]]
|[[Problem-v4.7(2024EN)|Problem]]
|[[Problem-v4.7(2024EN)|Problem]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[Signaling-v2.0(2024EN)| Signaling]]
|[[Signaling-v2.0(2024EN)| Signaling]]
Regel 115: Regel 116:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]]
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]]
|
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
|-style="vertical-align: top;"
|[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]]
|[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]]
Regel 121: Regel 122:
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN).png | full-size]]
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN).png | full-size]]
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model_Nieuw.png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model_Nieuw.png | full-size]]
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
|}
|}



Huidige versie van 9 jul 2024 11:24

Reason

Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.
The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.

Realisation

The following HCIMs are eligable to replace the reference to the HCIM Problem:

Depending on the nature of the concept of a HCIM currently referring to Problem, replacing the reference to the HCIM Problem requires a reference to one or more of the above HCIMs.
The table below shows, for each HCIM with a current reference to the HCIM Problem, which reference(s) will replace it.

HCIM Current reference Replacement reference(s) Current information model New information model
Admission Problem DiagnosticInsight
Reaction
Symptom

full-size

full-size
AdvanceDirective Problem DiagnosticInsight
full-size

full-size
Alert Problem DiagnosticInsight
HypersensitivityIntolerance 1

full-size

full-size
CareAgreement Problem DiagnosticInsight
full-size

full-size
CareTeam Problem DiagnosticInsight
Symptom

full-size

full-size
Encounter Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom

full-size

full-size
EpisodeOfCare Problem Condition 2
full-size

full-size
FamilyHistory Problem DiagnosticInsight
HypersensitivityIntolerance

full-size

full-size
MedicalDevice Problem DiagnosticInsight
full-size

full-size
MedicationAgreement Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom

full-size

full-size
MultidisciplinaryTeamMeeting Problem DiagnosticInsight
Symptom

full-size

full-size
NursingIntervention Problem DiagnosticInsight
Symptom

full-size

full-size
NutritionAdvice Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom

full-size

full-size
Procedure Problem DiagnosticInsight
Reaction
Symptom

full-size

full-size
Signaling Problem DiagnosticInsight
full-size

full-size
SkinDisorder Problem DiagnosticInsight
full-size

full-size
TreatmentObjective Problem DiagnosticInsight
HypersensitivityIntolerance
Symptom

full-size

full-size

Notes

1  HypersensitivityIntolerance reference should only be used when it is not medication related, as that is what the HCIM SurveillanceDecision is intended for.
2  An EpisodeOfCare relates to a condition that a health professional is following.